{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:09:23Z","timestamp":1792102163374,"version":"4.4.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ajog.2019.08.047","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T19:29:28Z","timestamp":1567711768000},"page":"437-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Does low-dose aspirin initiated before 11 weeks\u2019 gestation reduce the rate of preeclampsia?"],"prefix":"10.1016","volume":"222","author":[{"given":"Piya","family":"Chaemsaithong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Cuenca-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda N.","family":"Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda M.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liona C.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2019.08.047_bib1","series-title":"Chemistry: an introduction for medical and health sciences","first-page":"5","article-title":"Starting chemistry","author":"Jones","year":"2015"},{"key":"10.1016\/j.ajog.2019.08.047_bib2","series-title":"Murder, magic and medicine","author":"Mann","year":"1992"},{"key":"10.1016\/j.ajog.2019.08.047_bib3","series-title":"Aspirin and other salicylates","author":"Van","year":"1992"},{"key":"10.1016\/j.ajog.2019.08.047_bib4","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2019.08.047_bib5","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2019.08.047_bib6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2019.08.047_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2019.08.047_bib8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive Services Task Force recommendation statement","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2019.08.047_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ajog.2016.12.003","article-title":"Preventing preeclampsia with aspirin: does dose or timing matter?","volume":"216","author":"Tong","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ajog.2017.05.014","article-title":"Comment on: preventing preeclampsia with aspirin: does dose or timing matter?","volume":"217","author":"McMaster-Fay","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib12","doi-asserted-by":"crossref","first-page":"585.e1","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib14","doi-asserted-by":"crossref","first-page":"365.e1","DOI":"10.1016\/j.ajog.2017.04.035","article-title":"Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia","volume":"217","author":"Tolcher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib15","doi-asserted-by":"crossref","first-page":"685.e1","DOI":"10.1016\/j.ajog.2017.08.110","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia","volume":"217","author":"Wright","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib16","first-page":"81","article-title":"Antenatal care of preeclampsia: from the inverted pyramid to the arrow model?","volume":"44","author":"da Silva Costa","year":"2018","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib17","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","volume":"218","author":"Groom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.diabres.2018.05.002","article-title":"The first-trimester of pregnancy: a window of opportunity for prediction and prevention of pregnancy complications and future life","volume":"145","author":"Poon","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ajog.2019.08.047_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ajog.2018.03.018","article-title":"Optimal aspirin dosing for preeclampsia prevention","volume":"219","author":"Seidler","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajog.2017.12.238","article-title":"Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib22","doi-asserted-by":"crossref","first-page":"612.e1","DOI":"10.1016\/j.ajog.2018.02.014","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit","volume":"218","author":"Wright","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) Initiative on Pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2019.08.047_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.04.027","article-title":"A pharmacokinetic assessment of optimal dosing, preparation, and chronotherapy of aspirin in pregnancy","volume":"221","author":"Shanmugalingam","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib25","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2019.02.034","article-title":"Aspirin delays the development of preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/ajo.12982","article-title":"Prenatal screening for pre-eclampsia: frequently asked questions","volume":"59","author":"Wertaschnigg","year":"2019","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"7","key":"10.1016\/j.ajog.2019.08.047_bib27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2019.08.047_bib28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0015-0282(99)00088-6","article-title":"Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in\u00a0vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay","volume":"71","author":"Rubinstein","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2019.08.047_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajog.2004.09.029","article-title":"Heparin and aspirin attenuate placental apoptosis in\u00a0vitro: implications for early pregnancy failure","volume":"192","author":"Bose","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.placenta.2010.10.002","article-title":"Treatment with low-dose aspirin increased the level LIF and integrin beta3 expression in mice during the implantation window","volume":"31","author":"Zhao","year":"2010","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2019.08.047_bib31","first-page":"1021","article-title":"Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function","volume":"118","author":"Han","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2019.08.047_bib32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/art.38934","article-title":"Aspirin-triggered lipoxin prevents antiphospholipid antibody effects on human trophoblast migration and endothelial cell interactions","volume":"67","author":"Alvarez","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ajog.2019.08.047_bib33","first-page":"488","article-title":"Aspirin-triggered lipoxin prevents antiphospholipid antibody effects on human trophoblast migration and endothelial cell interactions","volume":"67","author":"Fang","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ajog.2019.08.047_bib34","first-page":"8526104","article-title":"Effects of aspirin and intrauterine balloon on endometrial repair and reproductive prognosis in patients with severe intrauterine adhesion: a prospective cohort study","volume":"2017","author":"Chen","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ajog.2019.08.047_bib35","first-page":"6337","article-title":"Transdermal estrogen gel and oral aspirin combination therapy improves fertility prognosis via the promotion of endometrial receptivity in moderate to severe intrauterine adhesion","volume":"17","author":"Chi","year":"2018","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.ajog.2019.08.047_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12785","article-title":"Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies","volume":"79","author":"Quao","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2019.08.047_bib37","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib38","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/humrep\/12.7.1567","article-title":"Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production","volume":"12","author":"Tulppala","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2019.08.047_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00404-007-0527-x","article-title":"Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study","volume":"278","author":"Fawzy","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2019.08.047_bib40","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/aogs.13420","article-title":"Acetylsalicylic acid does not prevent first-trimester unexplained recurrent pregnancy loss: a randomized controlled trial","volume":"97","author":"Blomqvist","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2019.08.047_bib41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0015-0282(97)00330-0","article-title":"Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study","volume":"68","author":"Weckstein","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2019.08.047_bib42","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.fertnstert.2004.02.082","article-title":"Low-dose aspirin in a short regimen as standard treatment in in\u00a0vitro fertilization: a randomized, prospective study","volume":"81","author":"Waldenstrom","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2019.08.047_bib43","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1093\/humrep\/dei020","article-title":"Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study","volume":"20","author":"Pakkila","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2019.08.047_bib44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmm005","article-title":"Low-dose aspirin for in\u00a0vitro fertilization: a systematic review and meta-analysis","volume":"13","author":"Gelbaya","year":"2007","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2019.08.047_bib45","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.fertnstert.2006.12.080","article-title":"Aspirin in women undergoing in\u00a0vitro fertilization treatment: a systematic review and meta-analysis","volume":"88","author":"Khairy","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2019.08.047_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.fertnstert.2007.06.033","article-title":"Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in\u00a0vitro fertilization","volume":"90","author":"Ruopp","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2019.08.047_bib47","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/humrep\/den476","article-title":"Does low-dose aspirin improve pregnancy rate in IVF\/ICSI? A randomized double-blind placebo controlled trial","volume":"24","author":"Dirckx","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2019.08.047_bib48","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/humrep\/den489","article-title":"Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF\/ICSI: a randomized, placebo-controlled, double-blind study","volume":"24","author":"Haapsamo","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2019.08.047_bib49","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.fertnstert.2008.07.1759","article-title":"Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial","volume":"92","author":"Lambers","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2019.08.047_bib50","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1093\/humrep\/deq286","article-title":"Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study","volume":"25","author":"Haapsamo","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2019.08.047_bib51","first-page":"Cd004832","article-title":"Aspirin for in\u00a0vitro fertilisation","author":"Siristatidis","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2019.08.047_bib52","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/j.1538-7836.2012.04886.x","article-title":"Low-dose aspirin for in\u00a0vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature","volume":"10","author":"Dentali","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2019.08.047_bib53","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/humrep\/det022","article-title":"Preconceptional low-dose aspirin for the prevention of hypertensive pregnancy complications and preterm delivery after IVF: a meta-analysis with individual patient data","volume":"28","author":"Groeneveld","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2019.08.047_bib54","doi-asserted-by":"crossref","first-page":"e7720","DOI":"10.1097\/MD.0000000000007720","article-title":"Efficacy evaluation of low-dose aspirin in IVF\/ICSI patients evidence from 13 RCTs: a systematic review and meta-analysis","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajog.2019.08.047_bib55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ajog.2019.08.047_bib56","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2019.08.047_bib57","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/AOG.0b013e3181deba40","article-title":"Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis","volume":"115","author":"Ziakas","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial","volume":"105","author":"Visser","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajog.2019.08.047_bib59","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT","volume":"10","author":"de Vries","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2019.08.047_bib60","first-page":"Cd004734","article-title":"Aspirin and\/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia","author":"de Jong","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2019.08.047_bib61","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/0961203315578765","article-title":"Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review","volume":"24","author":"Amengual","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.ajog.2019.08.047_bib62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00404-015-3782-2","article-title":"Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials","volume":"293","author":"Areia","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2019.08.047_bib63","doi-asserted-by":"crossref","first-page":"525.e1","DOI":"10.1016\/j.ajog.2017.01.026","article-title":"Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study","volume":"216","author":"Saccone","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib64","first-page":"1","article-title":"Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials","author":"Lu","year":"2018","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2019.08.047_bib65","doi-asserted-by":"crossref","first-page":"e12856","DOI":"10.1111\/aji.12856","article-title":"A\u00a0comparison of effectiveness among frequent treatments of recurrent spontaneous abortion: a Bayesian network meta-analysis","volume":"80","author":"Lv","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2019.08.047_bib66","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0015-0282(98)00160-5","article-title":"Obstetric outcome of singleton pregnancies conceived by in\u00a0vitro fertilization and ovulation induction compared with those conceived spontaneously","volume":"70","author":"Maman","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2019.08.047_bib67","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.AOG.0000114989.84822.51","article-title":"Perinatal outcomes in singletons following in\u00a0vitro fertilization: a meta-analysis","volume":"103","author":"Jackson","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"5 Pt 1","key":"10.1016\/j.ajog.2019.08.047_bib68","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/01.AOG.0000183593.24583.7c","article-title":"Assisted reproductive technology and pregnancy outcome","volume":"106","author":"Shevell","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.fertnstert.2015.09.007","article-title":"Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies","volume":"105","author":"Qin","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2019.08.047_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12958-016-0188-3","article-title":"Which one has a better obstetric and perinatal outcome in singleton pregnancy, IVF\/ICSI or FET? A systematic review and meta-analysis","volume":"14","author":"Zhao","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ajog.2019.08.047_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/uog.18930","article-title":"Risk of spontaneous preterm birth in singleton pregnancies conceived after IVF\/ICSI treatment: meta-analysis of cohort studies","volume":"51","author":"Cavoretto","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib72","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1053\/j.semperi.2017.07.001","article-title":"In\u00a0vitro fertilization and adverse obstetric and perinatal outcomes","volume":"41","author":"Sullivan-Pyke","year":"2017","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2019.08.047_bib73","first-page":"1","article-title":"ESHRE guideline: recurrent pregnancy loss. The ESHRE Guideline Group on RPL","author":"Atik","year":"2018","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.ajog.2019.08.047_bib74","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0301-2115(03)00269-0","article-title":"A\u00a0small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia","volume":"112","author":"Chiaffarino","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2019.08.047_bib75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3892\/etm.2016.3924","article-title":"Effect of a small dose of aspirin on quantitative test of 24-h urinary protein in patients with hypertension in pregnancy","volume":"13","author":"Liu","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ajog.2019.08.047_bib76","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/AOG.0000000000000736","article-title":"Low-dose aspirin and preterm birth: a randomized controlled trial","volume":"125","author":"Silver","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib77","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2019.08.047_bib78","article-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011","journal-title":"The Cochrane Collaboration"},{"key":"10.1016\/j.ajog.2019.08.047_bib79","series-title":"Cochrane Methods","article-title":"A\u00a0revised tool for assessing risk of bias in randomized trials","volume":"10","author":"Higgins","year":"2016"},{"key":"10.1016\/j.ajog.2019.08.047_bib80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1258\/1355819021927674","article-title":"Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice","volume":"7","author":"Higgins","year":"2002","journal-title":"J\u00a0Health Serv Res Policy"},{"key":"10.1016\/j.ajog.2019.08.047_bib81","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2019.08.047_bib82","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ajog.2019.08.047_bib83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-7-5","article-title":"Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data","volume":"7","author":"Friedrich","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajog.2019.08.047_bib84","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/humrep\/dep245","article-title":"Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in\u00a0vitro fertilization and early pregnancy","volume":"24","author":"Lambers","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2019.08.047_bib85","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/hr.2011.111","article-title":"Prevention of gravidic endothelial hypertension by aspirin treatment administered from the eighth week of gestation","volume":"34","author":"Bakhti","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ajog.2019.08.047_bib86","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1067\/mob.2000.106754","article-title":"Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial","volume":"183","author":"Pattison","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib87","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.4049\/jimmunol.154.8.3771","article-title":"Human placental HLA-G expression is restricted to differentiated cytotrophoblasts","volume":"154","author":"McMaster","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2019.08.047_bib88","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/uog.17351","article-title":"Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11\u201314 weeks: a randomized controlled study","volume":"49","author":"Scazzocchio","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib89","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1055\/s-0038-1675208","article-title":"The impact of aspirin on ultrasound markers of uteroplacental flow in low-risk pregnancy: secondary analysis of a multicenter RCT","volume":"36","author":"Mulcahy","year":"2019","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2019.08.047_bib90","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.ajpath.2016.08.010","article-title":"Low-dose acetylsalicylic acid treatment modulates the production of cytokines and improves trophoblast function in an in\u00a0vitro model of early-onset preeclampsia","volume":"186","author":"Panagodage","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2019.08.047_bib91","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/GCO.0b013e32832a0673","article-title":"Effects of low-dose aspirin in in-vitro fertilization","volume":"21","author":"Schisterman","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib92","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.rbmo.2016.02.001","article-title":"Strategies to manage refractory endometrium: state of the art in 2016","volume":"32","author":"Garcia-Velasco","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2019.08.047_bib93","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1100\/tsw.2010.113","article-title":"Lipoxin and aspirin-triggered lipoxins","volume":"10","author":"Romano","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.ajog.2019.08.047_bib94","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.freeradbiomed.2017.01.010","article-title":"Aspirin prevents TNF-alpha-induced endothelial cell dysfunction by regulating the NF-kappaB-dependent miR-155\/eNOS pathway: role of a miR-155\/eNOS axis in preeclampsia","volume":"104","author":"Kim","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ajog.2019.08.047_bib95","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jri.2017.10.044","article-title":"The effect of acetyl salicylic acid (Aspirin) on trophoblast-endothelial interaction in\u00a0vitro","volume":"124","author":"Xu","year":"2017","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.ajog.2019.08.047_bib96","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.placenta.2015.01.004","article-title":"Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1","volume":"36","author":"Li","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2019.08.047_bib97","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1067\/S0002-9378(03)00838-X","article-title":"Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes","volume":"189","author":"Kim","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib98","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/aje\/kwp131","article-title":"Placental vascular pathology findings and pathways to preterm delivery","volume":"170","author":"Kelly","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2019.08.047_bib99","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bpobgyn.2011.02.006","article-title":"Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae","volume":"25","author":"Romero","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib100","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2016.12.029","article-title":"Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta","volume":"216","author":"Labarrere","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.05.044","article-title":"Placental Bed Research: 1. The placental bed. From spiral arteries remodeling to the great obstetrical syndromes","volume":"221","author":"Brosens","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib102","doi-asserted-by":"crossref","unstructured":"Harris L, Benagiano M, D'Elios MM, Brosens I, Benagiano G. Placental Bed Research: 2. Functional and immunological nvestigations of the placental bed. Am J Obstet Gynecol 2019;221:457-69.","DOI":"10.1016\/j.ajog.2019.07.010"},{"key":"10.1016\/j.ajog.2019.08.047_bib103","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.placenta.2009.04.007","article-title":"Placental blood flow and the risk of preterm delivery","volume":"30","author":"Misra","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2019.08.047_bib104","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1177\/1933719117698574","article-title":"Preterm delivery as a unique pathophysiologic state characterized by maternal soluble FMS-like tyrosine kinase 1 and uterine artery resistance during pregnancy: a longitudinal cohort study","volume":"24","author":"Straughen","year":"2017","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2019.08.047_bib105","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1067\/mob.2002.127720","article-title":"Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes","volume":"187","author":"Kim","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib106","doi-asserted-by":"crossref","first-page":"559.e1","DOI":"10.1016\/j.ajog.2010.01.048","article-title":"The prognostic role of uterine artery Doppler investigation in patients with severe early-onset preeclampsia","volume":"202","author":"Meler","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib107","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \"Great Obstetrical Syndromes\" are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib108","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"Ogge","year":"2011","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2019.08.047_bib109","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/uog.12280","article-title":"Uteroplacental ischemia in early- and late-onset pre-eclampsia: a role for the fetus?","volume":"40","author":"Espinoza","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib110","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/14767058.2011.591461","article-title":"Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion","volume":"25","author":"Soto","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2019.08.047_bib111","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000359969","article-title":"Placental pathology in early-onset and late-onset fetal growth restriction","volume":"36","author":"Mifsud","year":"2014","journal-title":"Fetal Diagn Ther"},{"issue":"Suppl 4","key":"10.1016\/j.ajog.2019.08.047_bib112","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","article-title":"Why is placentation abnormal in preeclampsia?","volume":"213","author":"Fisher","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib113","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3109\/14767058.2014.976198","article-title":"The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion","volume":"28","author":"Kim","year":"2015","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2019.08.047_bib114","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/uog.15799","article-title":"Placental histological patterns and uterine artery Doppler velocimetry in pregnancies complicated by early or late pre-eclampsia","volume":"47","author":"Orabona","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib115","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ajog.2016.10.036","article-title":"Midtrimester uterine artery Doppler studies in predicting preeclampsia","volume":"216","author":"McMaster-Fay","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib116","doi-asserted-by":"crossref","first-page":"604.e1","DOI":"10.1016\/j.ajog.2018.09.036","article-title":"The clinical heterogeneity of preeclampsia is related to both placental gene expression and placental histopathology","volume":"219","author":"Benton","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib117","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(14)60157-4","article-title":"Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial","volume":"384","author":"Schisterman","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2019.08.047_bib118","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/AOG.0000000000001301","article-title":"Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses","volume":"127","author":"Ahrens","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib119","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib120","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)93025-7","article-title":"Aspirin and congenital malformations","volume":"1","author":"Slone","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2019.08.047_bib121","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/1099-1557(200005\/06)9:3<193::AID-PDS498>3.0.CO;2-I","article-title":"A\u00a0population-based case-control teratologic study of acetylsalicylic acid treatments during pregnancy","volume":"9","author":"Czeizel","year":"2000","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2019.08.047_bib122","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ajog.2004.10.598","article-title":"Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study","volume":"192","author":"Norgard","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib123","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0897.1995.tb00930.x","article-title":"Low-dose aspirin therapy and placental pathology in women with poor prior pregnancy outcomes","volume":"34","author":"Cusick","year":"1995","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2019.08.047_bib124","first-page":"83","article-title":"Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?","volume":"62","author":"Kalk","year":"2004","journal-title":"Neth J Med"},{"key":"10.1016\/j.ajog.2019.08.047_bib125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/ajo.12691","article-title":"Subsequent pregnancy outcome after mid-trimester termination of pregnancy for preeclampsia","volume":"58","author":"van Eerden","year":"2018","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2019.08.047_bib126","first-page":"178","article-title":"Prevention of preeclampsia","volume":"6","author":"Malha","year":"2016","journal-title":"Pregnancy Hypertension"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819310622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819310622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:28:28Z","timestamp":1757590108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937819310622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":126,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0002937819310622"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2019.08.047","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does low-dose aspirin initiated before 11 weeks\u2019 gestation reduce the rate of preeclampsia?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2019.08.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}